CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Condition(s):Candidiasis, Chronic MucocutaneousLast Updated:August 18, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Candidiasis, Chronic MucocutaneousLast Updated:August 18, 2022Completed
Condition(s):Pulmonary Alveolar Proteinosis (PAP); Severe Mucocutaneous CandidiasisLast Updated:February 22, 2024Completed
Condition(s):Chronic Mucocutaneous Candidiasis; Invasive Aspergillosis; CARD9; APECEDLast Updated:March 8, 2024Recruiting
Condition(s):Invasive Candidiasis; Mucocutaneous Candidiasis; Coccidioidomycosis; Histoplasmosis; Blastomycosis; Chronic Pulmonary Aspergillosis; Allergic Bronchopulmonary Aspergillosis; Invasive Pulmonary Aspergillosis; Recurrent Vulvovaginal Candidiasis; Other Emerging FungiLast Updated:October 30, 2023Completed
Condition(s):Polyendocrinopathies, AutoimmuneLast Updated:February 16, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.